TELO שולי הרווח הגולמי Telomir Pharma

Telomir Pharmaceuticals (TELO) is a young player in the longevity sector with a scientific approach, though its management structure is still in the formative stage. The actual gross margin displayed on this chart by the GURU.Markets service is 0.00. The business relies on the full outsourcing of molecule synthesis, which allows the company to maintain a lean staff and minimize the environmental footprint of its administrative offices.
פילוחי מדדים מקיפים ואנליטיקה עבור Telomir Pharmaceuticals (TELO)

Gross margin measures the efficiency of direct production, determining the profit share after deducting all operating costs associated with product creation. By analyzing gross margin variance, an investor can assess the impact of Telomir Pharmaceuticals (TELO) implementing green chemistry principles and ESG standards on the optimization of raw material costs during the development of innovative anti-aging therapeutic drugs.